Kura Oncology KURA Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's pre-tax income?
- Kura Oncology (KURA) reported pre-tax income of -$73.33M in Q1 2026.
- How has Kura Oncology's pre-tax income changed year-over-year?
- Kura Oncology's pre-tax income decreased by 28.2% year-over-year, from -$57.2M to -$73.33M.
- What is the long-term trend for Kura Oncology's pre-tax income?
- Over 3 years (2022 to 2025), Kura Oncology's pre-tax income has grown at a 27.0% compound annual growth rate (CAGR), from -$135.84M to -$278.37M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.